Last reviewed · How we verify
Foster
At a glance
| Generic name | Foster |
|---|---|
| Also known as | Relvar |
| Sponsor | Chiesi Farmaceutici S.p.A. |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Adaptation and Implementation of an Evidence-based Approach to Advance HIV Prevention and Care (NA)
- Thoracic Radiotherapy Plus Durvalumab in Elderly and/or Frail NSCLC Stage III Patients Unfit for Chemotherapy (PHASE2)
- A Cross-Cultural Randomized Controlled Trial Using a Multi-Level Mentalization Based Prevention Program to Foster Well-Being and Mental Health in Pre-Adolescent Children and Their Families (NA)
- Evaluating the Communication Between Patients and Providers in Cancer Clinics (NA)
- Optimizing Functional Recovery After Breast Cancer Treatment (NA)
- VR for Hope: A Brief VR Self-help Protocol to Enhance Hope and Well-being in Young Adults (NA)
- Using Tailored mHealth Strategies to Promote Weight Management Among Adolescent and Young Adult Cancer Survivors (NA)
- Evaluation of Child Care Staff Weight Management Program (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Foster CI brief — competitive landscape report
- Foster updates RSS · CI watch RSS
- Chiesi Farmaceutici S.p.A. portfolio CI